I

Insight Molecular Diagnostics Inc
D

IMDX

5.47500
USD
0.03
(0.46%)
مغلق
حجم التداول
4,544
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
157,045,239
المقالات

العنوان: Insight Molecular Diagnostics Inc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.